MUSCLE-INVASIVE BLADDER CANCER
Clinical trials for MUSCLE-INVASIVE BLADDER CANCER explained in plain language.
Never miss a new study
Get alerted when new MUSCLE-INVASIVE BLADDER CANCER trials appear
Sign up with your email to follow new studies for MUSCLE-INVASIVE BLADDER CANCER, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Bladder cancer drug combo shows promise in large global trial
Disease control OngoingThis study tests whether adding the immunotherapy drug durvalumab to standard chemotherapy before and after bladder removal surgery helps people with muscle-invasive bladder cancer. About 1,063 participants will receive either the drug combo or standard care. The goal is to see i…
Matched conditions: MUSCLE-INVASIVE BLADDER CANCER
Phase: PHASE3 • Sponsor: AstraZeneca • Aim: Disease control
Last updated May 17, 2026 02:21 UTC
-
New hope for bladder cancer patients who Can't take standard chemo
Disease control OngoingThis study tests two new drug combinations for people with muscle-invasive bladder cancer who cannot take the standard chemotherapy drug cisplatin. About 712 participants will receive either a combination of three drugs (durvalumab, tremelimumab, and enfortumab vedotin) or two dr…
Matched conditions: MUSCLE-INVASIVE BLADDER CANCER
Phase: PHASE3 • Sponsor: AstraZeneca • Aim: Disease control
Last updated May 17, 2026 02:20 UTC
-
New hope for bladder cancer: drug may stop return after surgery
Disease control OngoingThis study tests whether the drug atezolizumab can prevent bladder cancer from coming back after surgery to remove the bladder. It includes 761 people with high-risk muscle-invasive bladder cancer who had their bladder removed and still have cancer DNA in their blood. Participant…
Matched conditions: MUSCLE-INVASIVE BLADDER CANCER
Phase: PHASE3 • Sponsor: Hoffmann-La Roche • Aim: Disease control
Last updated May 17, 2026 02:03 UTC
-
New hope for bladder cancer: personalized drug cocktails under study
Disease control OngoingThis study is for people with muscle-invasive bladder cancer that has gotten worse after previous treatments. It tests several different drug combinations, chosen based on the specific genetic markers in each person's tumor. The main goal is to see if these combinations are safe …
Matched conditions: MUSCLE-INVASIVE BLADDER CANCER
Phase: PHASE1 • Sponsor: AstraZeneca • Aim: Disease control
Last updated May 15, 2026 11:53 UTC
-
Immunotherapy combo shows promise in bladder cancer fight
Disease control OngoingThis study tests whether adding the immunotherapy drug nivolumab (with or without another drug) to standard chemotherapy before and after surgery can improve outcomes for people with muscle-invasive bladder cancer. About 855 adults who are eligible for bladder removal surgery wil…
Matched conditions: MUSCLE-INVASIVE BLADDER CANCER
Phase: PHASE3 • Sponsor: Bristol-Myers Squibb • Aim: Disease control
Last updated May 14, 2026 12:14 UTC